Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Cernea

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
The Review of Diabetic Studies : RDS|January 21, 2012
The role of incretin therapy at different stages of diabetesSimona Cernea
Life (Basel, Switzerland)|February 24, 2024
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic InterplaySimona Cernea
World Journal of Gastroenterology|January 23, 2023
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinomaSimona Cernea, Danusia Onișor
Diabetes/Metabolism Research and Reviews|July 18, 2020
NAFLD in type 2 diabetes mellitus: Still many challenging questionsSimona Cernea, Itamar Raz
Diabetes Care|April 29, 2011
Therapy in the early stage: incretinsSimona Cernea, Itamar Raz
Biochemia Medica|November 26, 2013
Diabetes and beta cell function: from mechanisms to evaluation and clinical implicationsSimona Cernea, Minodora Dobreanu
American Journal of Therapeutics|October 1, 2019
Insulin Therapy: Future PerspectivesSimona Cernea, Itamar Raz
Timely Topics in Medicine. Cardiovascular Diseases|December 1, 2006
Noninjectable methods of insulin administrationSimona Cernea, Itamar Raz
Drugs of Today (Barcelona, Spain : 1998)|July 18, 2006
Noninjectable methods of insulin administrationSimona Cernea, Itamar Raz
Metabolism: Clinical and Experimental|August 19, 2021
Management of diabetic neuropathySimona Cernea, Itamar Raz
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
The Review of Diabetic Studies : RDS|January 21, 2012
The role of incretin therapy at different stages of diabetesSimona Cernea
Life (Basel, Switzerland)|February 24, 2024
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic InterplaySimona Cernea
World Journal of Gastroenterology|January 23, 2023
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinomaSimona Cernea, Danusia Onișor
Diabetes/Metabolism Research and Reviews|July 18, 2020
NAFLD in type 2 diabetes mellitus: Still many challenging questionsSimona Cernea, Itamar Raz
Diabetes Care|April 29, 2011
Therapy in the early stage: incretinsSimona Cernea, Itamar Raz
Biochemia Medica|November 26, 2013
Diabetes and beta cell function: from mechanisms to evaluation and clinical implicationsSimona Cernea, Minodora Dobreanu
American Journal of Therapeutics|October 1, 2019
Insulin Therapy: Future PerspectivesSimona Cernea, Itamar Raz
Timely Topics in Medicine. Cardiovascular Diseases|December 1, 2006
Noninjectable methods of insulin administrationSimona Cernea, Itamar Raz
Drugs of Today (Barcelona, Spain : 1998)|July 18, 2006
Noninjectable methods of insulin administrationSimona Cernea, Itamar Raz
Metabolism: Clinical and Experimental|August 19, 2021
Management of diabetic neuropathySimona Cernea, Itamar Raz
Pageof 5